content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation 

Osiris Therapeutics, Inc. (OSIR)

0
0.00
(0.00%)
 Sep 11, 3:45PM EDT
content_middle

Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.

OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.

Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Company Website
Previous Close: 
5.80
Open: 
5.76
Bid: 
N/A
Ask: 
N/A
1yr Target Price: 
4.00
Day's Range: 
5.76 - 5.89
52wk Range: 
7.01 - 19.30
Volume: 
7613
Average Daily Volume: 
24675
Market Capitalization: 
655.69M
Trailing Annual Dividend Yield: 
0.00
Shares Outstanding: 
34.53M
content_right

Pages